Inside Sarissa’s Healthy Returns

Why the Tiger Cub and Icahn alum is outperforming other health-care funds.

Alex Denner, chief investment officer of Sarissa Capital. (Andrew Harrer/Bloomberg)

Alex Denner, chief investment officer of Sarissa Capital.

(Andrew Harrer/Bloomberg)

It has been a rough year for many health-care-focused hedge funds, with a number of them either in the red or barely breaking even.

Not Sarissa Capital Management’s funds, however.

Its main long-short fund, Sarissa Capital, was up 18.1 percent in the first half of the year, while Sarissa Capital Domestic Fund II, the long-only fund it launched a year ago, was up 14.9

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Related